The American Hospital Association has responded to a recent request for comments from the Food and Drug Administration on its strategic plan for alleviating drug shortages.
The AHA understands it will take time for new FDA initiatives authorized in legislation enacted last year to show significant effect, but cautions that the shortage situation remains serious. “While the numbers of drugs newly in shortage began to decline in 2012, many of the existing shortages have not been resolved,” AHA notes in a letter to FDA Commissioner Margaret Hamburg, M.D. “There were 299 active drug shortages in the last quarter of 2012, the highest quarterly number to date.”
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access